-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on Aspen Aerogels, Lowers Price Target to $4

Benzinga·11/07/2025 15:08:08
Listen to the news
Barclays analyst David Anderson maintains Aspen Aerogels (NYSE:ASPN) with a Underweight and lowers the price target from $6 to $4.